These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11963295)

  • 1. [Cytochrome P450 enzymes and their role in drug interactions].
    Papp-Jámbor C; Jaschinski U; Forst H
    Anaesthesist; 2002 Jan; 51(1):2-15. PubMed ID: 11963295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of enzymes of drug metabolism.
    Meyer UA
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.
    Cerny MA
    Drug Metab Dispos; 2016 Aug; 44(8):1246-52. PubMed ID: 27084892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of opioid agents and the clinical impact of their active metabolites.
    Smith HS
    Clin J Pain; 2011; 27(9):824-38. PubMed ID: 21677572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions: Proteins, pumps, and P-450s.
    Shapiro LE; Shear NH
    J Am Acad Dermatol; 2002 Oct; 47(4):467-84; quiz 485-8. PubMed ID: 12271287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances: the cytochrome P450 enzymes.
    Slaughter RL; Edwards DJ
    Ann Pharmacother; 1995 Jun; 29(6):619-24. PubMed ID: 7663035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytochrome P450 enzymes in drug-drug interactions.
    Guengerich FP
    Adv Pharmacol; 1997; 43():7-35. PubMed ID: 9342171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease.
    Murray M
    Clin Pharmacokinet; 1992 Aug; 23(2):132-46. PubMed ID: 1511529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.